Are you Dr. Krishnamurthy?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 34 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Summary
- Dr. Savitri Krishnamurthy, MD is a board certified pathologist in Houston, Texas. She is currently licensed to practice medicine in Texas, California, and Massachusetts. She is affiliated with University of Texas M.D. Anderson Cancer Center.
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Cytopathology, 1998 - 1999
Memorial Sloan Kettering Cancer Center Oncologic PathologyFellowship, Selective Pathology, 1997 - 1998
Tufts Medical CenterResidency, Pathology-Anatomic and Clinical, 1994 - 1997
Medical College and Hospital KolkataClass of 1986
Certifications & Licensure
CA State Medical License 2004 - 2026
TX State Medical License 1999 - 2026
MA State Medical License 1997 - 2008- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Cytopathology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Wide-field Optical Coherence Tomography Imaging of Excised Breast Tissue. Start of enrollment: 2020 Aug 03
Publications & Presentations
PubMed
- Prospective and retrospective analysis of whole slide images of sentinel and targeted lymph node frozen sections in breast cancer.Qiqi Ye, Timothy Law, Dianna Klippel, Constance Albarracin, Hui Chen
Modern Pathology. 2025-01-07 - 1 citationsTrichorhinophalangeal syndrome 1 expression in breast and nonbreast metastases from Müllerian, lung, gastrointestinal tract, and pancreatic primary tumors by immunohis...Deepak Donthi, Qiong Gan, Qing Qing Ding, Savitri Krishnamurthy
Cancer Cytopathology. 2024-12-01 - Feasibility of breast conserving surgery alone in HER2-positive exceptional responders to neoadjuvant systemic therapy.Melissa P Mitchell, Simona F Shaitelman, Benjamin D Smith, Savitri Krishnamurthy, Vicente Valero
European Journal of Surgical Oncology. 2024-12-01
Press Mentions
MD Anderson Research Highlights for October 16, 2024October 16th, 2024- International Multi-Site Study of Ibex Medical Analytics’ AI-Powered Solution Demonstrates Improved HER2 Biomarker Scoring in Breast CancerOctober 15th, 2024
- MD Anderson Research Highlights for March 29, 2023March 28th, 2023
- Join now to see all
